Unknown

Dataset Information

0

Crystal Structures and Structure-Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors.

ABSTRACT: Indoleamine 2,3-dioxygenase 1 (IDO1) is considered as a promising target for the treatment of several diseases, including neurological disorders and cancer. We report here the crystal structures of two IDO1/IDO1 inhibitor complexes, one of which shows that Amg-1 is directly bound to the heme iron of IDO1 with a clear induced fit. We also describe the identification and preliminary optimization of imidazothiazole derivatives as novel IDO1 inhibitors. Using our crystal structure information and structure-activity relationships (SAR) at the pocket-B of IDO1, we found a series of urea derivatives as potent IDO1 inhibitors and revealed that generation of an induced fit and the resulting interaction with Phe226 and Arg231 are essential for potent IDO1 inhibitory activity. The results of this study are very valuable for understanding the mechanism of IDO1 activation, which is very important for structure-based drug design (SBDD) to discover potent IDO1 inhibitors.

SUBMITTER: Tojo S 

PROVIDER: S-EPMC4190630 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Crystal Structures and Structure-Activity Relationships of Imidazothiazole Derivatives as IDO1 Inhibitors.

Tojo Shingo S   Kohno Tetsuya T   Tanaka Tomoyuki T   Kamioka Seiji S   Ota Yosuke Y   Ishii Takayuki T   Kamimoto Keiko K   Asano Shigehiro S   Isobe Yoshiaki Y  

ACS medicinal chemistry letters 20140821 10

Indoleamine 2,3-dioxygenase 1 (IDO1) is considered as a promising target for the treatment of several diseases, including neurological disorders and cancer. We report here the crystal structures of two IDO1/IDO1 inhibitor complexes, one of which shows that Amg-1 is directly bound to the heme iron of IDO1 with a clear induced fit. We also describe the identification and preliminary optimization of imidazothiazole derivatives as novel IDO1 inhibitors. Using our crystal structure information and st  ...[more]

Similar Datasets

Unknown Synthesis and Structure–Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research
| S-EPMC8002823 | biostudies-literature
Unknown Structure-activity relationships of cycloalkylamide derivatives as inhibitors of the soluble epoxide hydrolase.
| S-EPMC3517215 | biostudies-literature
Unknown Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors.
| S-EPMC7555427 | biostudies-literature
Unknown Honaucins A-C, potent inhibitors of inflammation and bacterial quorum sensing: synthetic derivatives and structure-activity relationships.
| S-EPMC3361693 | biostudies-literature
Unknown Synthesis and structure-activity relationships of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives as 5-lipoxygenase inhibitors.
| S-EPMC7470027 | biostudies-literature
Unknown Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
| S-EPMC7144934 | biostudies-literature
Proteomics,Multiomics Structure-Activity Relationships of ENMs
2019-11-12 | PXD010614 | Pride
Unknown Thiazolidin-2-cyanamides derivatives as novel potent <i>Escherichia coli</i> β-glucuronidase inhibitors and their structure-inhibitory activity relationships.
| S-EPMC7534389 | biostudies-literature
Unknown Crystal Growth, Single Crystal Structure, and Biological Activity of Thiazolo-Pyridine Dicarboxylic Acid Derivatives.
| S-EPMC7643073 | biostudies-literature
Unknown Crystal Structures of PI3K? Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design.
| S-EPMC4027628 | biostudies-literature